Interactions between co-occuring leukaemogenic mutations identified in acute myeloid leukaemia genomes

Dr Vassiliou is a consultant haematologist and leads the Haematological Cancer Genetics group at the Sanger Institute. His group studies the pathogenesis and treatment of haematological malignancies with a particular focus on acute myeloid leukaemia. Additionally, the group develops and applies novel molecular methodologies for the diagnosis, classification and treatment of haematological cancers.